当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Jaleh Adibkia
Graphene-based multifunctional nanosystems have emerged as promising tools in the field of breast cancer detection and therapy. Breast cancer remains a significant global health concern, necessitating the development of innovative approaches to enhance early diagnosis and effective treatment. Graphene, with its exceptional electrical, mechanical, and biocompatible properties, offers a unique platform for the design of multifunctional nanosystems that can simultaneously detect and combat breast cancer. This review explores the recent advances in graphenebased nanosystems designed for breast cancer applications. It discusses the utilization of graphene’s superior properties for enhanced imaging and diagnosis, focusing on early-stage detection through the integration of various imaging modalities. Additionally, the review covers the integration of therapeutic agents such as chemotherapeutic drugs, gene therapies, and photothermal agents onto graphene-based nanocarriers, showcasing their potential for targeted therapy and minimizing off-target effects. The multifunctional nature of these nanosystems allows for the development of personalized and precision medicine approaches tailored to the specific characteristics of each patient’s breast cancer. Furthermore, the review highlights the challenges and prospects associated with graphenebased nanosystems, including biocompatibility, safety, and scalability.